BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    BINAXNOW COVID-19 AG SELF TEST 2CT

    MDR report key: 20049268 · Received August 23, 2024

    Report

    Report Number
    1221359-2024-00572
    Event Type
    Malfunction
    Date Received
    August 23, 2024
    Date of Event
    August 7, 2024
    Report Date
    November 27, 2024
    Manufacturer
    ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
    Product Code
    QKP
    UDI-DI
    00811877011408
    PMA / PMN Number
    EUA210264
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    US
    Reporter Occupation
    003

    Narratives

    Additional Manufacturer Narrative · 0

    TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 225415 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 195-160 / LOT 225415, TEST BASE PART NUMBER 195-430H / LOT 220852. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 225415 SHOWED THAT THE COMPLAINT RATE IS (B)(4). ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER, IT COULD POSSIBLY BE RELATED TO ISSUES INCLUDING THE SELF-TEST USER PERFORMANCE, INTERPRETATION OF THE RESULT, OR THE SPECIFIC PATIENT SAMPLE.

    Additional Manufacturer Narrative · 0

    THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION OR UPON RECEIPT OF NEW INFORMATION.

    Description of Event or Problem · 0

    THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2024. ADDITIONAL TESTING WAS PERFORMED (AT DOCTOR'S OFFICE) ON AN UNKNOWN DATE WITH AN UNKNOWN BRAND TEST (PLATFORM - UNKNOWN) WHICH GENERATED A POSITIVE RESULT. REPEAT TESTING WAS PERFORMED ON (B)(6) 2024 WHICH GENERATED A POSITIVE RESULT. THE CONSUMER STATED THE PATIENT WAS ILL BUT DIDN'T IDENTIFY THE SYMPTOMS SPECIFICALLY. THE CONSUMER STATED THAT THEY HAVE COVID-19 SYMPTOMS. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

    Description of Event or Problem · 0

    THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 ANTIGEN SELF-TEST PERFORMED ON (B)(6) 2024. ADDITIONAL TESTING WAS PERFORMED (AT DOCTOR'S OFFICE) ON AN UNKNOWN DATE WITH AN UNKNOWN BRAND TEST (PLATFORM - UNKNOWN) WHICH GENERATED A POSITIVE RESULT. REPEAT TESTING WAS PERFORMED ON (B)(6) 2024 WHICH GENERATED A POSITIVE RESULT. THE CONSUMER STATED THE PATIENT WAS ILL BUT DIDN'T IDENTIFY THE SYMPTOMS SPECIFICALLY. THE CONSUMER STATED THAT THEY HAVE COVID-19 SYMPTOMS. NO ADDITIONAL PATIENT INFORMATION, INCLUDING TREATMENT AND OUTCOME, WAS PROVIDED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1742033 BINAXNOW COVID-19 AG SELF TEST 2CT CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 225415 00811877011408

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Female